These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Human α-L-iduronidase uses its own N-glycan as a substrate-binding and catalytic module. Maita N; Tsukimura T; Taniguchi T; Saito S; Ohno K; Taniguchi H; Sakuraba H Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14628-33. PubMed ID: 23959878 [TBL] [Abstract][Full Text] [Related]
4. Production of α-L-iduronidase in maize for the potential treatment of a human lysosomal storage disease. He X; Haselhorst T; von Itzstein M; Kolarich D; Packer NH; Gloster TM; Vocadlo DJ; Clarke LA; Qian Y; Kermode AR Nat Commun; 2012; 3():1062. PubMed ID: 22990858 [TBL] [Abstract][Full Text] [Related]
10. Human N-acetylgalactosamine-4-sulphate sulphatase. Purification, monoclonal antibody production and native and subunit Mr values. Gibson GJ; Saccone GT; Brooks DA; Clements PR; Hopwood JJ Biochem J; 1987 Dec; 248(3):755-64. PubMed ID: 3435483 [TBL] [Abstract][Full Text] [Related]
11. Mucopolysaccharidosis type I subtypes. Presence of immunologically cross-reactive material and in vitro enhancement of the residual alpha-L-iduronidase activities. Schuchman EH; Desnick RJ J Clin Invest; 1988 Jan; 81(1):98-105. PubMed ID: 3121676 [TBL] [Abstract][Full Text] [Related]
13. Immunopurification and characterization of human alpha-L-iduronidase with the use of monoclonal antibodies. Clements PR; Brooks DA; McCourt PA; Hopwood JJ Biochem J; 1989 Apr; 259(1):199-208. PubMed ID: 2470345 [TBL] [Abstract][Full Text] [Related]